Omicron Virus - Standard Covid vaccines may be less effective against Omicron
January 24 2022
6:27 AM
banner-icon1 banner-icon2 banner-icon3


Omicron Virus

Standard Covid vaccines may be less effective against Omicron

Story by Kent Masterson - The Oregon Herald
Published on November 30, 2021 2:07 AM
Chicago - Several trusted Covid-19 vaccine manufactures believe covid vaccines may be less effective against the Omicron variant of the coronavirus. This is a new worry in financial markets about the future of the pandemic.

"There is no world, I think, where is the same level. We had with Delta," Moderna Chief Executive St├ęphane Bancel told the Financial Times in an interview.

"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to?.?.?. are like 'this is not going to be good.'"

Vaccine resistance may lead to more sickness and deaths and continue the pandemic. His comments started the selling in growth-exposed assets like oil, stocks and the Australian dollar.

He also said that the high number of mutations on the protein increase the virus uses to infect human cells means it was likely the current vaccines would need to be modified.

Bancel had earlier said that it could take months to begin shipping a vaccine that does work against Omicron.

Fear of the new variant has already triggered delays to some economic reopening plans and the reimposition of some travel and movement restrictions.

However, Russia on Monday said it would be ready to provide booster shots to protect against the Omicron coronavirus variant if needed.

At the same time, the Kremlin said the market reaction to the new strain was not based on scientific data. The heavily mutated Omicron variant made investors extremely nervoous on Friday.

Lst year, Russia hurriedly developed its two-dose Sputnik V vaccine and also created a one-shot Sputnik Light vaccine and says says both showed great results in trials.

Also, manufacturers said they have had difficulties producing the second dose of the vaccine, delaying efforts to increase output at home.

But Russia said on Monday that its vaccine would likely work against Omicron and that it would be ready to produce hundreds of millions of booster shots otherwise.

"Gamaleya Institute believes Sputnik V and Light will neutralise Omicron as they have highest efficacy versus other mutations," Kirill Dmitriev, head of the Russian Direct Investment Fund, which markets the vaccine overseas, said via the official Sputnik V Twitter account.

"In the unlikely case that a modification is needed, we will provide several hundred million of Sputnik Omicron boosters by Feb 20, 2022," he added.